Atropine pharmaceutical compositions
US11642338B2 · kind B2 · utility
2Cited by
11References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 11, 2021 |
| Grant date | May 9, 2023 |
| Priority date | — |
| Expiry date | Aug 28, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The inventive subject matter is directed to compositions and methods for sterile and storage stable low-dose atropine formulations with improved stability. Most preferably, the compositions presented herein are substantially preservative free and exhibit less than 0.35% tropic acid from degradation of atropine. Advantageously, contemplated formulations are also substantially free of preservatives.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.